BD, Beckman Coulter, Inc. (a subsidiary of Danaher) and Bio-Rad Laboratories, Inc. are Dominating in the Global Cell Sorting Market in 2019

Global Cell Sorting Market is expected to grow with the CAGR of 5.3% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-cell-sorting-market

Global cell sorting market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global cell sorting market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio. For instance, in January 2020, Miltenyi Biotec announced that they have launched GMP-compliant cell sorting system which is a first operator-free GMP-compliant cell sorting system. This development enhances the company product portfolio and generates adequate revenue.

BD is the dominating player in global cell sorting market. The other key players existing in the cell sorting market includes Miltenyi Biotec, Sony Biotechnology Inc. (a subsidiary of Sony Corporation), Union Biometrica, Inc. (a subsidiary of Harvard Bioscience), STEMCELL Technologies Inc., TERUMO BCT, INC. (a subsidiary of Terumo Corporation), Abgenex, Sysmex Europe GmbH (a subsidiary of Sysmex Corporation), Sepmag, NanoCellect Biomedical, Molecular Machines & Industries GmbH, Bio-Rad Laboratories, Inc., Cytonome/ST, LLC, On-chip Biotechnologies Co., Ltd. Corporation, Beckman Coulter, Inc. (a subsidiary of Danaher), Thermo Fisher Scientific Inc., Luminex Corporation, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Cellular Highways, Bay bioscience Co., Ltd. among others.

Cell Sorting Market BD:

BD is headquartered in New Jersey, U.S. and was founded in year 1897. The company focuses on instruments used for the diagnosis of the infectious disease. The company deals in multiple business segments such as medical, life sciences and interventional out of which life sciences is the market focused segment. The company offers variety of products under categories such as anesthesia delivery, biosciences, bio surgery, cervical cancer screening, diabetes care, drug delivery systems, gastrointestinal care, hazardous drug safety, hernia repair and fixation home care, infection prevention, infusion therapy, interventional specialties, molecular diagnostics and other variety of products out of which biosciences is the market focused category.

For instance,

  • In April 2018, BD has launched BD FACSymphony S6 cell sorter, which has ability to sort cell populations to better understand cell phenotypes for multi-omics research as well as immunology. This development has enhanced the company product portfolio and generated adequate revenue.

The company has wide global presence across the world as North America, Europe, South America, Asia-Pacific and Middle East and Africa with its various subsidiaries such as Accuri Cytometers, Inc. (U.S.), Accuri Cytometers (Germany), Ltd. (U.K.), Atto Bioscience, Inc. (U.S.) and B-D (Cambridge U.K.) Ltd. (U.K.) among others.

Beckman Coulter, Inc. (a subsidiary of Danaher):

Beckman Coulter, Inc. (a subsidiary of Danaher) is headquartered in California, U.S. and was founded in 1935. The company is engaged in the manufacturing and commercializing of advanced technology based laboratory products across the world. The company provide products under multiple categories such as core disciplines, workflow & informatics and solutions for (life sciences) in which solutions for (life sciences) is the market focused category.

For instance,

  • In June 2019, Beckman Coulter, Inc. (a subsidiary of Danaher) Life Sciences announced that they have acquired Cytobank which is a single cell data analysis, software as a service (SaaS) company. This development enhanced the credibility of the company

The company has wide global presence across North America, South America, Europe, Asia-Pacific and Middle East and Africa.

Bio-Rad Laboratories, Inc.:

Bio-Rad Laboratories, Inc. is headquartered in California, U.S. and was founded in 1952. The company focuses on distributing and manufacturing life science products, analytical instrumentation and clinical diagnostics. The company offers analysers and clinical materials among others. The company has multiple business segments which are life science, clinical diagnostics and other operations out of which life science is the market focused segment. The company provides products under categories such as life science research, clinical diagnostics, spectroscopy, process separations, food science and life science education out of which life science research is the market focused category.

For instance,

  • In April 2015, Bio-Rad Laboratories, Inc. announced that they have launched S3e Cell Sorter (488/640 nm) which is an easy-to-use product. This development has enhanced the company product portfolio and generated adequate revenue.

The company has presence in North America, Europe, South America, Asia-Pacific and Middle East and Africa. The company has various subsidiaries such as Bio-Rad Laboratories Pty. Ltd. (Australia), Bio-rad Laboratories GmbH (Austria), Bio-Rad Laboratories N.V. (Belgium) and GnuBIO Inc. (U.S.) among others.